名稱(chēng) | CD86/CHO |
型號(hào) | CBP74070 |
報(bào)價(jià) | |
特點(diǎn) | CD86/CHO,凍存條件:90% FBS+10% DMSO |
產(chǎn)品搜索
產(chǎn)品分類(lèi)
相關(guān)文章
- JCI:華人科學(xué)家發(fā)現(xiàn)促進(jìn)乳腺癌進(jìn)展轉(zhuǎn)移的表觀修飾閱讀者
- CNV參考品
- atcc細(xì)胞的細(xì)胞核分離原理說(shuō)明
- 對(duì)細(xì)胞株的污染鑒定與處理解讀
- 人乳頭瘤病毒HPV核酸檢測(cè)標(biāo)準(zhǔn)品
- 【產(chǎn)品推介】NRAS診斷標(biāo)準(zhǔn)品
- eLife:為何肺癌靶向治療會(huì)失???看看科學(xué)家們?cè)趺凑f(shuō)
- DKK-1細(xì)胞篩選模型
- 腫瘤細(xì)胞的生長(zhǎng)受哪些因素的作用呢?
- PDGFRA靶點(diǎn)藥物細(xì)胞篩選模型
聯(lián)系我們
聯(lián)系人:蔣經(jīng)理
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > 腫瘤免疫細(xì)胞株 > CBP74070CD86/CHO
- 詳細(xì)內(nèi)容
CBP74070 | |
I. Background | |
B7-2 (CD86) signaling through CTLA4 (CD152) has been shown to inhibit T- cell activation. This co-inhibitory pathway can be overactive in many tumors, enabling cancers to escape the host’s immune system. CTLA4-blocking antibodies, including Ipilimumab (Yervoy) and Tremelimumab, have shown clinical efficacy in treating cancer. | |
II. Description | |
Recombinant CHO cells constitutively expressing human CD86. | |
III. Introduction | |
Host Cell: | CHO |
Expressed gene: | CD86 |
Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Synonym(s): | T-lymphocyte activation antigen CD86, B7.2, FUN-1, B70, BU63, CD86, B72 |
Freeze Medium: | 90% FBS+10% DMSO |
Culture Medium: | F12K+10%FBS+500ug/ml hygromycin |
Mycoplasma Testing: | Negative |
Storage: | Liquid nitrogen |
Application(s): | Ligand of CD28&Binding Assay,FACS |
IV. Description of Host Cell Line | |
Organism: | Cricetulus griseus, hamster, Chinese |
Tissue: | Ovary |
Disease: | Hamster Chinese ovary |
Morphology: | Epitheloid cell |
Growth Properties: | Adherent |
Ⅴ. Representative Data | |
Figure 1. Recombinant CHO cells expressing human CD86. | |